Clinical Trial Assay & CDx Development in the Era of Precision Medicine – Planning for Success
Dr. Jude O’Donnell discusses Clinicial Trial Assay & CDx Development in the era of Precision Medicine.
Synopsis
- Regulatory considerations for assay development, validation & commercialization
- Choosing the right diagnostic partner: experience, ability to deliver, transparency & trust
- Biomarker-led clinical trial assay and companion diagnostic development & validation challenges
- Case study showcasing a recent Almac Biomarker Program with a large global pharma partner
View Resource
Please complete this form to view
the Webinar
This website uses cookies. By continuing to browse the site, you are agreeing to our
use of cookies